A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 55 (1), 51-62
- https://doi.org/10.1016/0021-9150(85)90165-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1984
- Long-term treatment of type III hyperlipoproteinemia with clofibrateAtherosclerosis, 1981
- Tween-20 increases the immunoreactivity of apolipoprotein A-I in plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrateAtherosclerosis, 1980
- Effects of nicotinic acid therapy on high-density ldpoprotein metabolism in type II and type IV hyperlipoproteinaemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- High density lipoproteins during hypolipidemic therapyAtherosclerosis, 1980
- Studies on the polymorphism of human apolipoprotein A-IBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A MetabolismJCI Insight, 1979
- Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in manNature, 1977
- Metabolic relationships among the plasma lipoproteinsJCI Insight, 1972